Q4 2017 Holdings
Filed 2018-02-14 | 11 holdings | $133.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2018-02-23) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $131.8M | 413,858 | 99.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $967.0K | 10,000 | 0.7% |
| Bioverativ Inc | COM | 09075R100 | $62.8K | 1,165,000 | 0.0% |
| Bioverativ IncA | COM | 09075E100 | $62.8K | 1,165,000 | 0.0% |
| Medicines Co | COM | 584688105 | $52.5K | 1,922,000 | 0.0% |
| Innoviva Inc(INVA)A | COM | 45781M101 | $51.9K | 3,660,705 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $42.1K | 257,300 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CLA | 46333X108 | $24.7K | 1,650,000 | 0.0% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $10.6K | 182,300 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $7.2K | 2,500,000 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $3.2K | 1,025,000 | 0.0% |
| Apricus Biosciences Inc | COM NEW | 03832V307 | $2.7K | 1,447,906 | 0.0% |